We are now posting in the format of a forum but soon we will work from a homepage with sections and subsections. That looks not only more sophistcated, but it also creates room for us to work with embedded picures - graphics - pdf's etc.
The DEA Special Testing and Research Laboratory (Dulles, Virginia) recently received two exhibits, each containing 10 pink pentagonal tablets, suspected to be methandrostenolone mimic tablets containing a different steroid (see Photo ). The exhibits were seized in Erie, Pennsylvania (details not provided), and were submitted to the laboratory by the Pennsylvania State Police Laboratory. Analysis by GC/MS and NMR gave no library matches; however, structural elucidation software suggested 17α-methyldromostanolone (a non-controlled ?designer? steroid). Comparison with a standard confirmed this identification. This was the first submission of 17α-methyldromostanolone in any form to the Special Testing and Research Laboratory.
The DEA Special Testing and Research Laboratory (Dulles, Virginia) recently received two exhibits, each containing 10 pink pentagonal tablets, suspected to be methandrostenolone mimic tablets containing a different steroid (see Photo ). The exhibits were seized in Erie, Pennsylvania (details not provided), and were submitted to the laboratory by the Pennsylvania State Police Laboratory. Analysis by GC/MS and NMR gave no library matches; however, structural elucidation software suggested 17α-methyldromostanolone (a non-controlled ?designer? steroid). Comparison with a standard confirmed this identification. This was the first submission of 17α-methyldromostanolone in any form to the Special Testing and Research Laboratory.
Comment